Axovant Gene Therapies to Present at 2019 Cell & Gene Meeting on the Mesa

BASEL, Switzerland, Sept. 25, 2019 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (Nasdaq: AXGT), a clinical-stage company developing innovative gene therapies, today announced that Parag Meswani, Pharm.D., senior vice president, commercial strategy & operations, will present at the annual Cell & Gene Meeting on the Mesa at 4:30 PM PT on October 3, 2019 in Carlsbad, California.